Showing results (391-400 of 421) with videos related to
Sort By:
Pageof 43
Human Pathology|February 17, 2022
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosisSamuel Ruder, Yan Gao, Yi Ding, et al.Advances in Anatomic Pathology|December 13, 2012
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue MicroarraySarah Hawley, Ladan Fazli, Jesse K McKenney, et al.Ebiomedicine|June 21, 2016
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate CancerJeri Kim, John W Davis, Eric A Klein, et al.JAMA Oncology|May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerMartin G Sanda, Ziding Feng, David H Howard, et al.Journal of the National Cancer Institute|January 20, 2005
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Phyllis J Goodman, Eric A Klein, et al.The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.European Urology|May 16, 2020
A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African AncestryBurcu F Darst, Peggy Wan, Xin Sheng, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2010
Validation of genome-wide prostate cancer associations in men of African descentBao-Li Chang, Elaine Spangler, Stephen Gallagher, et al.Lancet (London, England)|July 7, 2018
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trialDipen J Parekh, Isildinha M Reis, Erik P Castle, et al.Pageof 43